Impact Of Insulin Containing Regimen Vs Triple Oral Hypoglycaemic Agent Therapy On Health-Related Quality Of Life, Economic, And Clinical Outcomes In Poorly Controlled Type 2 Diabetes Outpatients In Yogyakarta

Type 2 Diabetes Mellitus (DM) is a progressive disease, and blood glucose control finally will get poorer because the function of pancreatic beta cells will decrease. Monotherapy with oral antidiabetics will not be effective for long so it is followed by two to three oral antidiabetics as combinatio...

Full description

Saved in:
Bibliographic Details
Main Author: Tri , Murti Andayani
Format: Thesis
Language:English
Published: 2010
Subjects:
Online Access:http://eprints.usm.my/42814/1/TRI_MURTI_ANDAYANI.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Type 2 Diabetes Mellitus (DM) is a progressive disease, and blood glucose control finally will get poorer because the function of pancreatic beta cells will decrease. Monotherapy with oral antidiabetics will not be effective for long so it is followed by two to three oral antidiabetics as combination therapy, and finally, type 2 DM patients will need exogenous insulin therapy. This research compared the addition and switching of therapy to insulin with triple oral therapy measuring three outcome parameters, i.e., clinical, humanistic and economic outcomes.